| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 1D
Jourdeuil K et al. (2025)
|
Xla Wt + zmym2
NF22-23 (in situ hybridization)
|
|
|
|
Fig.5.Col.5
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF10.5 (in situ hybridization)
|
|
|
|
|
Fig.5.Col.2
Mukherjee S et al. (2020)
|
Xtr Wt + sox17a MO + sox17b.1/b.2 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig. 1 C row 2 col 2
Walentek P et al. (2015)
|
Xla Wt + atp4a MO
NF15-18 (in situ hybridization)
|
|
pneumonia
|
|
Fig. S 2 B
Walentek P et al. (2015)
|
Xla Wt + atp4a MO
NF15-18 (in situ hybridization)
|
|
pneumonia
|
|
Fig. S 3 B top
Walentek P et al. (2015)
|
Xla Wt + atp4a MO + animal cap explant
NF19 (RT-PCR)
|
|
pneumonia
|
|
|
Fig. S 3 B top
Walentek P et al. (2015)
|
Xla Wt + atp4a MO + animal cap explant
NF25 (RT-PCR)
|
|
pneumonia
|
|
|
Fig. S 3 B top
Walentek P et al. (2015)
|
Xla Wt + atp4a MO + animal cap explant
NF32 (RT-PCR)
|
|
pneumonia
|
|
fig.2.a.12
Afelik S et al. (2006)
|
Xla Wt + ptf1a-GR + DEX
NF41 (in situ hybridization)
|
|
|
|
fig.2
Sinner D et al. (2004)
|
Xla Wt + Activin + animal cap explant
NF11 (RT-PCR)
|
|
|